ロード中...
Giant Cell Tumor With Pathologic Fracture: Should We Curette or Resect?
BACKGROUND: Approximately one in five patients with giant cell tumor of bone presents with a pathologic fracture. However, recurrence rates after resection or curettage differ substantially in the literature and it is unclear when curettage is reasonable after fracture. QUESTIONS/PURPOSES: We theref...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3563806/ https://ncbi.nlm.nih.gov/pubmed/22926445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-012-2546-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|